NovaBridge Biosciences Payments to Acquire Short-term Investments
NovaBridge Biosciences (NBP) reported Payments to Acquire Short-term Investments of $49.96 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-04-07
- NovaBridge Biosciences payments to acquire short-term investments for the quarter ending 2020-12-31 was 2.22B CNY, a 4728.56% increase year-over-year.
- NovaBridge Biosciences payments to acquire short-term investments for the quarter ending 2019-12-31 was 46.00M CNY.
CNY
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|
| 2021-12-31 | 10.17B CNY 20-F · filed 2022-04-29 | ||
| 2020-12-31 | 2.22B CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 2.49B CNY 20-F · filed 2022-04-29 | |
| 2020-09-30 | 270.85M CNY 6-K · filed 2021-02-05 | ||
| 2019-12-31 | 46.00M CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 134.00M CNY 20-F · filed 2022-04-29 | |
| 2019-09-30 | 88.00M CNY 6-K · filed 2021-02-05 |
USD
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $0.00 derived: sum of 2 quarters · filed 2026-04-07 | $49.96M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $49.96M 6-K · filed 2025-12-18 | ||
| 2025-06-30 | $49.96M 6-K · filed 2025-10-06 | |||
| 2024-12-31 | $81.43M derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $139.22M derived: sum of 2 quarters · filed 2026-04-07 | $194.75M 20-F · filed 2026-04-07 | |
| 2024-09-30 | $57.79M derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | $113.31M 6-K · filed 2025-12-18 | ||
| 2024-06-30 | $55.52M 6-K · filed 2025-10-06 | |||
| 2023-12-31 | $100.00M 20-F · filed 2026-04-07 | |||
| 2022-12-31 | $767.51M 20-F · filed 2025-04-03 | |||
| 2021-12-31 | $1.60B 20-F · filed 2022-04-29 | |||
| 2020-12-31 | $342.02M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $381.91M 20-F · filed 2021-04-28 | ||
| 2020-09-30 | $39.89M 6-K · filed 2021-02-05 | |||
| 2019-12-31 | $19.25M 20-F · filed 2020-04-29 |